C World Wide Group Holding A Syndax Pharmaceuticals Inc Transaction History

C World Wide Group Holding A

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 03, 2019	SELL	$4.26 - $6.86 $54,936 - $88,466	-12,896 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$3.6 - $8.42 $1,191 - $2,787	-331 Reduced 2.5%	12,896 $57,000
Q3 2018 Nov 05, 2018	BUY	$6.33 - $8.08 $13,128 - $16,757	2,074 Added 18.6%	13,227 $107,000
Q1 2018 May 03, 2018	SELL	$8.71 - $14.82 $3,022 - $5,142	-347 Reduced 3.02%	11,153 $159,000
Q4 2017 Feb 07, 2018	SELL	$7.8 - $12.94 $14,040 - $23,292	-1,800 Reduced 13.53%	11,500 $101,000
Q3 2017 Nov 06, 2017	BUY	$10.9 - $12.73 $144,970 - $169,309	13,300	13,300 $156,000

229

89.9M

1.01M

692K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $811M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.